1. Phase 1, pharmacogenomic, dose‐expansion study of pegargiminase plus pemetrexed and cisplatin in patients with ASS1‐deficient non‐squamous non‐small cell lung cancer. (12th August 2021) Authors: Szlosarek, Peter W.; Wimalasingham, Akhila G.; Phillips, Melissa M.; Hall, Peter E.; Chan, Pui Ying; Conibear, John; Lim, Louise; Rashid, Sukaina; Steele, Jeremy; Wells, Paula; Shiu, Chiung‐Fang; Kuo, Chih‐Ling; Feng, Xiaoxing; Johnston, Amanda; Bomalaski, John; Ellis, Stephen; Grantham, Marianne... Journal: Cancer medicine Issue: Volume 10:Number 19(2021) Page Start: 6642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗